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PECULIARITIES OF HEMODYNAMIC AND METABOLIC 
INDICATORS IN PATIENTS WITH ARTERIAL 
HYPERTENSION AND CONCOMITANT OBESITY 
DEPENDING ON PLASMA RENIN ACTIVITY. 
 
The aim of the research: to evaluate the effect of plasma renin 
activity on the state of hemodynamic and neurohumoral parameters 
in obese hypertensive patients.  
Materials and Methods: Anthropometric, biochemical, 
automated methods of immune analysis, spectrophotometric, 
instrumental, statistical methods were used to examine 200 
hypertensive patients with class I–II obesity aged 45–55 years. 
Patients were divided into two groups depending on plasma renin 
activity: the first group included 21 patients with low-renin 
hypertension, the second – 179 patients with high-renin hypertension.  
Results: Patients with HRAH had higher blood pressure BP 
(DBP, p = 0.004, SBP and mean blood pressure, p<0.001 for both 
indicators), higher CIMT bifurcation (p = 0.003) and cPWV (p = 
0.023), larger size of the left ventricle and its MM (p = 0.039) 
compared with patients with LRAH. The HRAH was associated with 
a more pronounced imbalance of the oxidative stress system – 
antioxidant protection, higher levels of leptin, total cholesterol and 
LDL cholesterol. In the absence of differences in glycemic levels, 
patients with HRAH had significantly higher insulin levels and more 
pronounced IR, as assessed by the HOMA index. Patients with low 
plasma renin activity had significantly lower serum aldosterone 
levels with significantly higher ARR levels than patients with high 
plasma renin activity. 
Conclusions: Features of cardiovascular remodeling and 
neurohumoral status depending on the phenotype of hypertension in 
patients with concomitant obesity have been established.  
Keywords: arterial hypertension, low-renin hypertension, high-
renin hypertension, plasma renin activity, obesity.– 
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ОСОБЛИВОСТІ ГЕМОДИНАМІЧНИХ ТА МЕТАБОЛІЧНИХ 
ПОКАЗНИКІВ У ХВОРИХ НА АРТЕРІАЛЬНУ ГІПЕРТЕНЗІЮ 
ІЗ СУПУТНІМ ОЖИРІННЯМ В ЗАЛЕЖНОСТІ ВІД 
АКТИВНОСТІ РЕНІНУ В ПЛАЗМІ.  
  
Мета роботи полягала в оцінюванні впливу активності реніну 
плазми на стан гемодинамічних параметрів та метаболічних показ-
ників у хворих на артеріальну гіпертензією із супутнім ожирінням. 
Матеріали і методи: Обстежено 200 пацієнтів із артеріальною 
гіпертензією (АГ) та ожирінням (ОЖ) І–ІІ ступенів. Пацієнти були 
поділені на дві групи залежно від активності реніну плазми: до 
першої групи ввійшов 21 пацієнт з низькореніновою АГ (НРАГ), до 
другої – 179 пацієнтів з високореніновою АГ (ВРАГ). Антропомет-
ричні, біохімічні, автоматизовні методи імунного аналізу, спектро-
фотометричні, інструментальні та статистичні методи використову-
вали при проведенні дослідження. 
Результати. Пацієнти з ВРАГ мали вищі рівні АТ (ДАТ, p = 
0,004, САТ і середній АТ, p < 0,001 для обох показників), більші 
значення показників ТІМ ЗСА на рівні біфуркації (p = 0,003) і ШПХ 
ЗСА (p = 0,023), більші розміри лівого шлуночка та ММЛШ (р = 
0,039) порівняно з пацієнтами із НРАГ. ВРАГ асоціювалася з більш 
вираженим дисбалансом системи оксидативного стресу – антиокси-
дантного захисту, вищими рівнями лептину, загального ХС і ХС 
ЛПНЩ. Пацієнти з ВРАГ мали достовірно вищі рівні інсуліну і 
більш виражену ІР за відсутності відмінностей щодо рівнів глікемії. 
Достовірно нижчий рівень сироваткового альдостерону за достові-
рно більш високого показника АРК установлено в пацієнтів із 
НРАГ порівняно із групою пацієнтів з ВРАГ.  
Висновки. Встановлено особливості серцево-судинного ремо-
делювання та нейрогуморального статусу залежно від фенотипу АГ 
у пацієнтів із супутнім ожирінням. 
Ключові слова: артеріальна гіпертензія, низькоренінова АГ, ви-
сокоренінова АГ, активність реніну плазми, ожиріння.  
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Introduction 
Hypertension remains one of the few nosologies 
without a common etiological basis. In most 
publications on hypertension, you can find 
formulated with varying degrees of categorical, but 
unchanging in essence, the statement that the 
etiology of hypertension (essential arterial 
hypertension) still remains undisclosed. At the very 
best, information is given about the multifactorial 
origin of the disease, followed by a more or less 
complete list of these factors: genetic predisposition, 
overweight and obesity, sedentary lifestyle, smoking, 
diabetes, kidney disease, diet rich in fats and salt. 
Probably, the list can be extended, but it does not 
clarify the etiology of hypertension, it is very 
difficult to assess the causal role of each of these 
factors in the origin of the disease in a particular 
patient with subsequent cardiovascular complications 
[1–4]. 
The discovery of forms of arterial hypertension 
with known mechanisms allows for targeted 
effective therapy and in some cases to achieve a 
complete cure. However, the contingent of patients 
with LRAH belongs to the group of patients with 
unclear etiology, as its development is associated 
with polygenic systems and with a significant 
influence of environmental factors, ethnicity, age, 
blood pressure, the presence of comorbid 
pathologies: kidney disease, diabetes, metabolic 
syndrome [3, 5, 6]. 
Attempting to understand the essence of this 
form, attention was paid to aldosterone as one of the 
most effective factors in the suppression of renin, on 
the one hand, and the formation of hypertensive 
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status – on the other hand [4, 7]. As the mechanisms 
of aldosterone involvement in the pathogenesis of 
low-renin hypertension deepened, the main genetic 
and physiological links in the development of 
various forms and syndromes of LRAG were 
established. The study of genetic and physiological 
mechanisms of the low-renin form of arterial 
hypertension provides an illustrative example of how 
penetration into the intimate mechanisms of blood 
pressure regulation in each case allows identifying 
individual-specific syndromes and establishing the 
original causes of the disease [8–12]. Progress has 
obviously been done in revealing the causes and 
mechanisms of essential hypertension. 
Analysis of the forms and manifestations of 
LRAH gives an example of how you can expand the 
pool of hypertensive conditions of known etiology 
and gradually move towards the disclosure of 
multiple and diverse, but still largely unclear causes 
of the origin of the essential hypertension [13, 14]. 
Thus, the study of the activity of such 
components of RAAS as renin and aldosterone, their 
evaluation in hypertensive patients depending on the 
presence and absence of obesity, IR, is an urgent 
problem that requires detailed study. 
The aim of the research: to evaluate the effect 
of plasma renin activity on the state of hemodynamic 
and neurohumoral parameters in hypertension 
patients with concomitant obesity.  
Clinical characteristics of patients and 
research methods. We examined 200 hypertensive 
patients with class I–II obesity aged 45–55 years. 
Patients were divided into two groups depending on 
plasma renin activity: the first group included 21 
patients with low-renin hypertension, the second – 
179 patients with high-renin hypertension. 
Measurements of height, body weight, and BMI 
calculation formed physical examination of patients. 
The waist-to-hip ratio was determined due to 
patients' waist circumference (WC) and hip 
circumference (HC). Office BP was measured in 
accordance with the 2018 ESC/ESH Guidelines for 
the management of AH [15]. Difference between 
SBP and DBP evaluated as pulse BP. Average BP 
was calculated by the formula: 
Average BP = 0.42 × (SBP – DBP) + DBP 
Morphofunctional properties of the myocardium 
were evaluated during ultrasound examination of the 
heart in one-dimensional, two-dimensional and 
Doppler modes by conventional methods. The 
volumes of left and right atria (LAV and RAV, 
respectively), end-systolic and end-diastolic 
diameters (LVESD and LVEDD, respectively) of the 
left ventricle (LV), diameters of LA and aorta (LAD 
and AD, respectively) were evaluated. The ejection 
fraction (EF) was calculated by the formula: 
EF = (EDV – ESV) / EDV, 
where ESV and EDV are the end-systolic and 
end-diastolic LV volumes, respectively. 
The thickness of the posterior wall of the LV and 
the thickness of the interventricular septum in the 
systole (TPWs and TIVSs, respectively) and diastole 
(TPWd and TIVSd, respectively) were measured. 
The relative wall thickness of the LV (RWT) was 
calculated by the formula: 
RWT = (TPWd + TIVSd) / LVEDD 
The LV myocardial mass index (LVMI) was 
calculated as the ratio of the LV myocardial mass 
(LVM) to the surface area of the body (S): 
LVMI = LVM / S 
Left ventricular diastolic function was evaluated 
by pulmonary artery blood flow and transmitral 
diastolic blood flow in pulsed Doppler with the 
determination of the following parameters: 
maximum early LV filling rate in spectral mode (E), 
maximum late (atrial) filling speed (A), ratio of 
maximal rates of early and late filling of LV at 
spectral mode (E/A), time of isovolumic relaxation 
of LV (IVRT), time of deceleration early diastolic 
flow rate (DT), maximum early LV filling rate at 
tissue mode (e´), mean pulmonary artery pressure 
(AP) by Kitabatake, ratio of E and e´ (E/e´). For 
studying endothelial function, the degree of 
endothelium-dependent vasodilation (EDVD) in 
reactive hyperemia was determined in all patients. 
Investigations were carried out using a broadband 
linear transducer 5–12 MHz Doppler color mapping 
with three readings being taken arteries at 15-min 
intervals between samples on the left and right 
brachial arteries, according to the method of 
Celermajer D. S. (in the modification of the method 
by Ivanova O. V.) [16, 17]. Normally, the maximum 
vasodilation of the brachial artery should exceed 
10% of the original diameter. Simultaneously, we 
measured the intima media thickness (СIMT) of the 
carotid artery (CA, 2 cm proximal to the bifurcation 
of the common CA). The pulse wave velocity 
(PWV) in the carotid artery (сPWV) was determined 
by the W-Track method; determination of the PWV 
in the abdominal aorta (aPWV) was performed using 
a phased sensor. 
In this study we defined venous blood glucose 
concentration and insulin levels with standard 
biochemical methods. The patients were also tested 
for glucose tolerance. Insulin resistance (IR) was 
determined using the homeostasis model assessment 
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index (HOMA-IR). The activity of the renin–
angiotensin–aldosterone system (RAAS) was 
evaluated by the levels of aldosterone and plasma 
renin activity (PRA), as well as by the aldosterone-
renin ratio (ARR). Low-renin hypertension was set at 
< 0.65 ng/ml/h, and high-renin hypertension was set 
at ≥ 0.65 ng/ml/h. The inflammatory activity was 
evaluated by the levels of interleukin 6 (IL-6) and C-
reactive protein (CRP). The functional state of 
adipose tissue was assessed by blood levels of leptin 
and adiponectin. The intensity of peroxide oxidation 
of lipids was assessed for indicators of prooxidant 
activity – the levels of malonic dialdehyde (MDA) 
and diene conjugates (DC), and the state of the 
antioxidant protection system – by the total 
antioxidant activity. Lipid metabolism was assessed 
by total cholesterol, triglycerides, LDL and HDL 
cholesterol.  
The statistical processing of the obtained data 
was carried out using the package of statistical 
software “SPSS 17” (IBM), Microsoft Office Exel-
2003. The data are presented as mean values ± 
standard deviation. Significance was set at a p value 
of < 0.05 in all cases. 
The study protocol was approved by the Ethics 
Committee. All participants were informed about the 
aim of the study and signed a written consent form. 
Results and Discussion. Among patients with 
hypertension and concomitant obesity 89.5% have 
HRAH, and 10.5%, respectively, LRAH. It was 
found that BMI in patients with HRAH was higher 
than in patients with LRAH (p = 0.000). In the 
absence of differences in glycemic levels, patients 
with HRAH had significantly (p = 0.000) higher 
insulin levels and more pronounced IR, as assessed 
by the HOMA index (Table 1). 
Table 1 – Anthropometric indicators and neurohumoral parameters of obese hypertensive patients with 
LRAH and HRAH 
Indicators 
AH + obesity 
LRAH HRAH 
р 
n = 21 n = 179 
Weight [kg] 92,00 ± 8,56 101,91 ± 10,61 0,000 
BMI [kg/m2] 31,46 ± 1,09 35,20 ± 2,65 0,000 
Waist [cm] 108,71 ± 7,13 107,51 ± 7,58 0,491 
Hip [cm] 115,43 ± 10,87 115,96 ± 8,07 0,786 
Waist-to-hip ratio 0,95 ± 0,11 0,93 ± 0,11 0,514 
Total cholesterol [mmol/L] 5,84 ± 0,46 6,11 ± 0,47 0,016 
Triglycerides [mmol/L] 1,89 ± 0,32 2,01 ± 0,39 0,189 
LDL cholesterol [mmol/L] 4,05 ± 0,56 4,89 ± 0,54 0,000 
HDL cholesterol, [mmol/L]  0,99 ± 0,04 1,00 ± 0,10 0,556 
Blood glucose [mmol/L] 4,93 ± 0,27 5,07 ± 0,50 0,206 
Insulin [µU/mL] 8,67 ± 0,66 15,78 ± 5,06 0,000 
HOMA-IR 1,90 ± 0,12 3,58 ± 1,28 0,000 
HbA1c (%) 5,19 ± 0,24 5,29 ± 0,52 0,357 
Overall antioxidant protection [mmol/L] 1,13 ± 0,06 1,05 ± 0,06 0,000 
MDA [nmol/mL] 32,52 ± 3,59 36,01 ± 3,28 0,000 
DC [nmol/mL] 30,06 ± 1,88 32,12 ± 3,42 0,008 
IL-6 [pg/mL] 137,57 ± 8,73 138,58 ± 8,19 0,596 
CRP [mg/L] 7,50 ± 1,07 7,51 ± 1,18 0,991 
Aldosteron [ng/dl] 11,94 ± 1,98 17,49 ± 2,11 0,000 
PRA , ng/ml/hour 0,55 ± 0,06 2,63 ± 0,48 0,000 
ARR 21,83 ± 3,65 6,92 ± 1,79 0,000 
Adiponectin [ng/mL] 6,44 ± 0,11 6,49 ± 0,47 0,086 
Leptin [ng/mL] 12,22 ± 1,06 15,40 ± 2,43 0,000 
BMI – body mass index; ARR – aldosterone-renin ratio; CRP – C-reactive protein; DC – diene conjugates; MDA – malonic 
dialdehyde; HbA1c – glycated hemoglobin; HDL – high density lipoprotein; LDL – low-density lipoprotein; IL-6 – 
interleukin 6; HOMA-IR – Homeostatic Model Assessment for Insulin Resistance 
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Table 2 – Hemodynamic parameters of obese hypertensive patients with LRAH and HRAH 
Indicators 
AH + obesity 
LRAH HRAH 
р 
n = 21 n = 179 
SBP [mm Hg] 171.44 ± 4.48 175.24 ± 2.98 0.000 
DBP [mm Hg] 101.25 ± 3.00 103.24 ± 2.98 0.004 
Heart rate [bpm] 72.60 ± 1.92 72.71 ± 1.52 0.511 
Pulse BP [mm Hg] 70.20 ± 4.00 72.00 ± 4.14 0.053 
Average BP [mm Hg] 130.73 ± 3.12 133.48 ± 2.17 0.000 
CIMT [mm] 0.90 ± 0.07 0.91 ± 0.09 0.401 
CIMT bifurcation [mm] 1.27 ± 0.13 1.37 ± 0.15 0.003 
cPWV [m/s] 8.06 ± 1.32 8.62 ± 1.04 0.023 
aPWV [m/s] 8.28 ± 0.86 8.51 ± 1.07 0.362 
EDVD (%) 7.14 ± 0.96 6.88 ± 1.18 0.340 
TIVSd [cm] 1.12 ± 0.14 1.18 ± 0.11 0.050 
TIVSs [cm] 1.40 ± 0.18 1.47 ± 0.15 0.045 
TPWd [cm] 1.13 ± 0.14 1.19 ± 0.14 0.106 
TPWs [cm] 1.49 ± 0.17 1.62 ± 0.36 0.086 
LVEDD[cm] 4.74 ± 0.31 4.91 ± 0.34 0.029 
LVESD[cm]  3.18 ± 0.11 3.22 ± 0.28 0.503 
EDV [mL] 104.95 ± 17.06 114.09 ± 19.11 0.037 
ESV [mL] 40.46 ± 3.34 42.17 ± 9.38 0.408 
EF (%) 62.85 ± 4.95 63.24 ± 3.00 0.072 
LVM [g] 235.60 ± 55.83 267.57 ± 67.79 0.039 
LVMI [g/m
2
] 115.45 ± 25.98 126.32 ± 31.75 0.133 
RWT 0.47 ± 0.06 0.48 ± 0.04 0.500 
LAD [mm] 38.60 ± 2.25 38.24 ± 3.32 0.627 
AD [mm] 34.30 ± 2.07 32.90 ± 1.34 0.000 
Mean pulmonary AP [mm Hg]  
by Kitabatake 
16.10 ± 2.90 16.31 ± 3.26 0.774 
RAV [mL] 41.55 ± 4.75 39.16 ± 4.74 0.030 
LAV [mL] 49.05 ± 2.93 52.36 ± 5.03 0.004 
е´[cm/s]  12.10 ± 2.18 11.42 ± 2.23 0.187 
E [cm/s] 71.72 ± 13.18 66.43 ± 9.70 0.024 
A [cm/s] 85.54 ± 10.08 77.87 ± 10.65 0.002 
E/A 0.83 ± 0.07 0.87 ± 0.16 0.347 
DT [s] 0.15 ± 0.08 0.15 ± 0.10 0.931 
IVRT [s] 0.14 ± 0.02 0.12 ± 0.02 0.000 
Е/е´ 6.06 ± 1.26 5.96 ± 2.88 0.695 
BP – blood pressure; DBP – diastolic blood pressure; SBP – systolic blood pressure; A – maximum late (atrial) filling 
speed; AP – artery pressure; DT – time of deceleration early diastolic flow rate; E – filling rate in spectral mode; e – 
maximum early LV filling rate at tissue mode; E/A – ratio of maximal rates of early and late filling of LV at spectral mode; 
E/e – ratio of E and e; IVRT – time of isovolumic relaxation of LV; EDVD – endothelium-dependent vasodilatation; EF – 
ejection fraction; CA – carotid artery; IMT – intima-media thickness; LVM – left ventricular mass; LVMI – left ventricular 
mass index; PWV – pulse wave velocity (cPWV – carotid artery, aPWV – abdominal aorta); RAV – right atrial volume; 
LAV – left atrial volume; TIVSd – thickness of the interventricular septum (diastole); TIVSs – thickness of the 
interventricular septum (systole); TPWd – thickness of the posterior wall of the left ventricle in diastole; TPWs – the 
thickness of the posterior wall of the left ventricle in systole; LVEDD – end-diastolic diameters; LVESD – end-systolic 
diameters; EDV – end-diastolic volume; ESD – end-systolic volume; RWT – relative wall thickness; LAD – left atrial 
diameter; AD – aortic diameter. 
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A negative cross-link between RAAS activity 
and insulin signal may be responsible for impaired 
regulation of carbohydrate metabolism and 
increased risk of cardiovascular events and 
mortality. More pronounced IR in HRAH was 
accompanied by significantly (p = 0.000) higher 
levels of leptin at the specified phenotype of AH, 
that confirms the association of IR with leptin 
resistance. At the same time, in the group of 
hypertensive patients with low renin activity, a 
lower level of serum aldosterone (p = 0.000) was 
observed at a higher ARR (p = 0.000) than in the 
group with a high PRA (Table 1). These features 
can be explained by the fact that LRAH in 
population-based studies shows a bimodal 
distribution of aldosterone levels, which confirms 
the existence of two broad categories of LRAH: 
people with low aldosterone levels and people with 
normal or high aldosterone, whereas the presence of 
high levels of renin increases the level of 
angiotensin II (AT II) and aldosterone, which is one 
of the main mechanisms of regulation of RAAS 
activity [1, 18, 19]. 
In the absence of differences in HDL cholesterol 
and triglycerides, patients with HRAH had higher 
levels of total cholesterol (p = 0.016) and LDL 
cholesterol (p = 0.000) compared with patients with 
LRAH (Table 1). The results can be explained by 
the directed interaction between RAAS and LDL 
cholesterol activity: on the one hand, increased 
RAAS activity is confirmed in unstable 
atherosclerotic plaques, and on the other hand, 
increased LDL cholesterol can stimulate RAAS 
[20]. It is known that blood pressure II stimulates 
the synthesis and incorporation of cholesterol into 
the vascular wall, as well as the oxidation of LDL. 
Moreover, population-based studies suggest that in 
patients with AH AT II has a stimulating effect on 
LDL oxidation and their degradation by 
macrophages [20–22]. 
Patients with HRAH had higher BP levels than 
patients with LRAH: the significance of the 
difference in DBP levels was p = 0.004, the 
significance of the differences between SBP and 
mean BP p <0.001 for both indicators (Table 1). 
The severity of cardiovascular remodeling in 
obese hypertensive patients was significantly higher 
in the HRAH presence. Thus, patients with HRAH 
had significantly higher CIMT bifurcation (p = 
0.003) and cPWV (p = 0.023) compared with 
patients with LRAH. In addition, in the presence of 
HRAH, significantly larger sizes of LV and its 
LVM were noted (Table 2). 
More pronounced cardiovascular remodeling in 
the presence of HRAH was accompanied by a 
greater imbalance of the oxidative stress system – 
antioxidant protection in this phenotype AH: the 
significance of the difference in overall antioxidant 
protection was p = 0.000, and the significance of 
differences MDA and DC – p = 0.000 and p = 
0.008, respectively (Table 1). 
 
Conclusions  
Features of cardiovascular remodeling and neu-
rohumoral status depending on the phenotype of 
hypertension in patients with concomitant obesity 
have been established.  
 
Prospects for future research 
Further study of the forms and manifestations of 
different phenotypes of hypertension and, above all, 
low-renin hypertension will provide an opportunity 
to expand the pool of hypertensive conditions with 
known etiology, a similar picture of the disease and 
biochemical and molecular genetic traits and 
markers. This will expand the possibilities of 
disclosing multiple and various, completely 
incomprehensible causes of the origin of essential 
hypertension. 
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